Medical Students Articles

Med Student

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hilchey SP et al. – The results support the finding that the ATP–ectonucleotidase–adenosine system mediates T cell anergy in a human tumor. In addition, these studies suggest that the A2A/B AR as well as CD39 are novel pharmacological targets for augmenting cancer immunotherapy.

Related Articles

Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09    Relevance Score: 96%

Do male lymphoma survivors have impaired sexual function?
Journal of Clinical Oncology, 10/29/09    Relevance Score: 94%

Subcutaneous ‘lipoma-like’ B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT
Annals of Oncology, 10/29/09    Relevance Score: 94%

Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach
Hematological Oncology, 10/27/09    Relevance Score: 94%

Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
Journal of Clinical Oncology, 10/12/09    Relevance Score: 93%

Today in Hematology/Oncology...keeping you current

Epothilones in prostate cancer
Urologic Oncology: Seminars and Original Investigations, 11/25/09

Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09

Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: Correlation with intravesical recurrence following transurethral resection
Urologic Oncology: Seminars and Original Investigations, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address